1851 Safety analysis, correlation with response and previous treatments of the association of everolimus (EVE) and exemestane (EXE) in 181 metastatic breast cancer patients (MBC). (September 2015) - Moscetti, L.; Vici, P.; Sperduti, I.; Fabbri, M.A.; Natoli, C.; Mancini, M.L.; Sini, V.; D'Onofrio, L.; Pizzuti, L.; Vaccaro, A.; Magnolfi, E.; Magri, V.; et al.